Secondary prevention in acute myocardial infarction

BMJ. 1998 Mar 14;316(7134):838-42. doi: 10.1136/bmj.316.7134.838.

Authors

R H Mehta¹, K A Eagle

Affiliation

¹ University of Michigan Hospital, Division of Cardiology, Taubman Center, Ann Arbor 48109-0366, USA.

No abstract available

Publication types

Review

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Anti-Arrhythmia Agents / therapeutic use
Anticoagulants / therapeutic use
Aspirin / therapeutic use
Calcium Channel Blockers / therapeutic use
Humans
Hypolipidemic Agents / therapeutic use
Life Style
Myocardial Infarction / prevention & control*
Smoking Cessation

Substances

Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Anti-Arrhythmia Agents
Anticoagulants
Calcium Channel Blockers
Hypolipidemic Agents
Aspirin